1887

Abstract

Hepatitis B surface antigen (HBsAg) is the main diagnosis marker for hepatitis B virus (HBV) infection. In this study, a novel HBV mutant from an HBV-positive blood donor with false-negative results during HBsAg screening was identified. DNA sequencing discovered two mutations at nt 353 (A to T) and nt 349 (T to A), leading to Thr to Met and Ser to Thr substitutions at aa 118 and 117 of HBsAg, respectively. Further analysis showed that eight of ten HBsAg ELISA kits failed to detect this HBsAg mutant. A mutagenesis assay indicated that the Thr to Met substitution at aa 118 was the determinant for escape from HBsAg ELISA detection. A small-scale screening of blood donors identified two individuals infected by this unique HBV mutant, suggesting a certain level of prevalence among the general population. In conclusion, our study identified the aa 118 mutation in HBV surface antigen and provided information for improvement of HBV diagnosis products.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000427
2016-05-01
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jgv/97/5/1210.html?itemId=/content/journal/jgv/10.1099/jgv.0.000427&mimeType=html&fmt=ahah

References

  1. Bartholomeusz A., Tehan B. G., Chalmers D. K.. ( 2004;). Comparisons of the HBV and HIV polymerase, and antiviral resistance mutations. Antivir Ther 9: 149–160 [PubMed].
    [Google Scholar]
  2. Candotti D., Allain J. P.. ( 2009;). Transfusion-transmitted hepatitis B virus infection. J Hepatol 51: 798–809 [CrossRef] [PubMed].
    [Google Scholar]
  3. Carman W. F.. ( 1997;). The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4: (Suppl. 1) 11–20 [CrossRef] [PubMed].
    [Google Scholar]
  4. Carman W. F., Karayiannis P., Waters J., Thomas H. C., Zanetti A. R., Manzillo E., Zuckerman A. J.. ( 1990;). Vaccine-induced escape mutant of hepatitis B virus. Lancet 336: 325–329 [CrossRef] [PubMed].
    [Google Scholar]
  5. Deng L., Tang H.. ( 2011;). Hepatitis B virus drug resistance to current nucleos(t)ide analogs: mechanisms and mutation sites. Hepatol Res 41: 1017–1024 [CrossRef] [PubMed].
    [Google Scholar]
  6. Dienstag J. L.. ( 2008;). Hepatitis B virus infection. N Engl J Med 359: 1486–1500 [CrossRef] [PubMed].
    [Google Scholar]
  7. Echevarría J. M., Avellón A.. ( 2008;). Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay. J Med Virol 80: 598–602 [CrossRef] [PubMed].
    [Google Scholar]
  8. Kuhns M. C., Kleinman S. H., McNamara A. L., Rawal B., Glynn S., Busch M. P., REDS Study Group. ( 2004;). Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy. Transfusion 44: 1332–1339 [CrossRef] [PubMed].
    [Google Scholar]
  9. Mangold C. M., Streeck R. E.. ( 1993;). Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein. J Virol 67: 4588–4597 [PubMed].
    [Google Scholar]
  10. Mizuochi T., Okada Y., Umemori K., Mizusawa S., Yamaguchi K.. ( 2006;). Evaluation of 10 commercial diagnostic kits for in vitro expressed hepatitis B virus (HBV) surface antigens encoded by HBV of genotypes A to H. J Virol Methods 136: 254–256 [CrossRef] [PubMed].
    [Google Scholar]
  11. Nan Y., Wang R., Shen M., Faaberg K. S., Samal S. K., Zhang Y. J.. ( 2012;). Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology 432: 261–270 [CrossRef] [PubMed].
    [Google Scholar]
  12. Ott J. J., Stevens G. A., Groeger J., Wiersma S. T.. ( 2012;). Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 30: 2212–2219 [CrossRef] [PubMed].
    [Google Scholar]
  13. Patel D., Nan Y., Shen M., Ritthipichai K., Zhu X., Zhang Y. J.. ( 2010;). Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation. J Virol 84: 11045–11055 [CrossRef] [PubMed].
    [Google Scholar]
  14. Radziwill G., Tucker W., Schaller H.. ( 1990;). Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J Virol 64: 613–620 [PubMed].
    [Google Scholar]
  15. Seddigh-Tonekaboni S., Waters J. A., Jeffers S., Gehrke R., Ofenloch B., Horsch A., Hess G., Thomas H. C., Karayiannis P.. ( 2000;). Effect of variation in the common a determinant on the antigenicity of hepatitis B surface antigen. J Med Virol 60: 113–121 [CrossRef] [PubMed].
    [Google Scholar]
  16. Shepard C. W., Simard E. P., Finelli L., Fiore A. E., Bell B. P.. ( 2006;). Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 28: 112–125 [CrossRef] [PubMed].
    [Google Scholar]
  17. Szmuness W., Stevens C. E., Zang E. A., Harley E. J., Kellner A.. ( 1981;). A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1: 377–385 [CrossRef] [PubMed].
    [Google Scholar]
  18. Tian Y., Xu Y., Zhang Z., Meng Z., Qin L., Lu M., Yang D.. ( 2007;). The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J Clin Microbiol 45: 2971–2978 [CrossRef] [PubMed].
    [Google Scholar]
  19. Weber B.. ( 2006;). Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78: (Suppl. 1), S59–S65 [CrossRef] [PubMed].
    [Google Scholar]
  20. WHO ( 2015;). Hepatitis B fact sheet no. 204 Geneva: WHO;.
    [Google Scholar]
  21. Zuckerman A. J.. ( 2000;). Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 355: 1382–1384 [CrossRef] [PubMed].
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000427
Loading
/content/journal/jgv/10.1099/jgv.0.000427
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error